View Dan Weiss' Articles BY TICKER:
Show Summaries | Hide Summaries
- Preview of AspenBio's Potentially Blockbuster Clinical Trials
- AspenBio Pharma Poised for a Breakout Year
- AspenBio: Bursting with Possibilities
- A Look at ISTA's Strong Pipeline
- Outlook on Sector Performance: More Pain Ahead for Financials
- Six Sectors Presenting Opportunities as Obama Takes Office
- The Bush Legacy Market Returns
- Nine Market Predictions for 2009
- Calendar Year S&P 500 Returns in Perspective
- Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals
- Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair
- 5 Attractive Small/Midcaps Poised for Strong Returns
- Summary of August Sector Performance
- Allied Defense Group: Turnaround Progress
GSI, Intersections: Two Attractive Microcaps
Aug. 17, 2008 • Comment!
- How Far Has Market Leadership Shifted?
- Six Stocks with Possibilities
- Opportunities in Small-Cap Asset Management Firms
- Lev Acquisition Looks Good but More Clarity Needed
- 10 Winning Stock Themes in a McCain Administration
- 10 Winning Stock Themes in an Obama Administration
- 2nd Quarter 2008: A Tale of Three Seasons
- A Look at the Russell 1000 and the Russell 2000
- Countering Greenberg's Report on Hanesbrands
- The Trade-Down Effect
Penn Deal is Stalled: What is Best for Investors?
Jun. 4, 2008 • 1 Comment
- Is Lampert Making the Grade at Sears Holdings?
- Lumber Liquidators Solid as Hardwood While Housing is Weak
- Another Strong Quarter for Advocat
- Three Short Ideas: Standard Pacific, Under Armour and Trump Entertainment
- What about the Pocket Recessions?
- 3 Long Ideas: Mitcham Industries, Key Technology and New Frontier Media